Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

249
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K
Rh Blood Group01:19

Rh Blood Group

2.7K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.7K
Blood Transfusion01:15

Blood Transfusion

2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K
Blood Typing01:10

Blood Typing

2.3K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence guided antiplatelet treatment: time to move from bench to bedside.

Thrombosis research·2009
Same author

Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment.

Cardiovascular therapeutics·2009
Same author

Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.

Expert review of cardiovascular therapy·2009
Same author

Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.

Thrombosis and haemostasis·2009
Same author

Indications for the use of diagnostic implantable and external ECG loop recorders.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2009
Same author

Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features.

Stroke·2009

Related Experiment Video

Updated: Jan 11, 2026

Disorders of Erythrocytes
01:27

Disorders of Erythrocytes

2.0K

Platelets and heart failure.

Irene Chung1, Gregory Y H Lip

  • 1Haemostasis, Thrombosis, and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, UK.

European Heart Journal
|October 10, 2006
PubMed
Summary

Platelet abnormalities are common in heart failure, increasing risks for blood clots and sudden death. This review examines platelets' role in heart failure pathophysiology and the potential benefits of antiplatelet therapy.

Area of Science:

  • Cardiology
  • Hematology
  • Thrombosis Research

Background:

  • Heart failure (HF) significantly elevates risks for venous thromboembolism, stroke, and sudden cardiac death.
  • Platelet abnormalities are frequently observed in HF patients, but their precise contribution to thromboembolic events is not fully understood.
  • The efficacy and role of antiplatelet agents in managing HF complications remain areas of active investigation.

Purpose of the Study:

  • To review the current understanding of platelet activation and dysfunction in the context of heart failure pathophysiology.
  • To elucidate the impact of platelet dysfunction on clinical outcomes in patients with heart failure.
  • To discuss the influence of existing heart failure therapies on platelet function and explore the potential of antiplatelet therapy in HF management.

More Related Videos

Immune Compatible Blood Transfusion and Agglutination
02:45

Immune Compatible Blood Transfusion and Agglutination

14.0K
Rh Blood Group
01:19

Rh Blood Group

2.7K

Related Experiment Videos

Last Updated: Jan 11, 2026

Disorders of Erythrocytes
01:27

Disorders of Erythrocytes

2.0K
Immune Compatible Blood Transfusion and Agglutination
02:45

Immune Compatible Blood Transfusion and Agglutination

14.0K
Rh Blood Group
01:19

Rh Blood Group

2.7K

Main Methods:

  • Comprehensive literature review focusing on studies investigating platelet function, pathophysiology, and therapeutic interventions in heart failure.
  • Analysis of existing data on the association between platelet abnormalities and thromboembolic complications in heart failure.
  • Evaluation of research on the effects of heart failure medications and antiplatelet agents on platelet activity and patient outcomes.

Main Results:

  • Platelet activation and dysfunction are implicated in the prothrombotic state associated with heart failure.
  • Evidence suggests a link between specific platelet abnormalities and adverse outcomes, including thromboembolism and mortality in HF.
  • The impact of various HF treatments on platelet function requires further clarification, as does the precise role of antiplatelet drugs.

Conclusions:

  • Platelets play a significant, though not fully defined, role in the thromboembolic complications of heart failure.
  • Further research is warranted to clarify the clinical utility of monitoring platelet function and employing antiplatelet therapies in heart failure management.
  • Understanding platelet behavior in HF is crucial for developing targeted strategies to mitigate thrombotic risks and improve patient prognosis.